LB
LB Pharmaceuticals Inc Common Stock
LBRX · NASDAQ
$46.25 -2.01% (-$0.95)
1M +1.92%
Market Cap $1.33B
P/E Ratio -
Div. Yield -
ROE 25.91%
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/B 3.99x
P/E N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 28.07%
ROE 25.91%
ROA 23.69%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 15.08x
Int. coverage N/A
Stability
21 /100
Unstable Beta 0.42x
EPS volatility 567.68%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na LBRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Heather D. Turner
Employees
49
Headquarters
New York
Nadcházející události
05 LIS
Earnings
Upcoming earnings report